Qiu Chunguang, Han Zhanying, Lu Wenjie
Department of Cardiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, 430030, China.
J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):660-3. doi: 10.1007/s11596-007-0610-3.
To explore the relation of angiotensin-converting enzyme (ACE) and angiotensin II type 1 receptor (AT1R) gene polymorphism with coronary heart disease (CHD) and the severity of coronary artery stenosis, 130 CHD patients who underwent coronary angiography were examined for the number of affected coronary vessels (> or = 75% stenosis) and coronary Jeopardy score. The insertion/deletion of ACE gene polymorphism and AT1R gene polymorphism (an A-->C transversion at nucleotide position 1166) were detected by using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) in CHD patients and 90 healthy serving as controls. The results showed that DD genotype and of ACE were more frequent in CHD patients than that in control group (38.5% vs 14.4%, P<0.001). The frequency of the AT1R A/C genotypes did not differ between the patients and the controls (10% vs 13.1%, P>0.05). The relative risk associated with the ACE-DD was increased by AT1R-AC genotype. Neither the number of affected coronary vessels nor the coronary score differed among the ACE I/D genotypes (P>0.05). But the number of affected coronary vessels and the coronary score were significantly greater in the patients with the AT1R-AC genotype than in those with the AA genotype (P<0.05). In conclusion, DD genotype may be risk factor for CHD and MI in Chinese people, and is not responsible for the development of the coronary artery stenosis. The AT1R-C allele may increase the relative risk associated with the ACE-DD genotype, and may be involved in the development of the stenosis of coronary artery.
为探讨血管紧张素转换酶(ACE)和血管紧张素II 1型受体(AT1R)基因多态性与冠心病(CHD)及冠状动脉狭窄严重程度的关系,对130例行冠状动脉造影的CHD患者检查其受累冠状动脉血管数量(狭窄≥75%)及冠状动脉危险评分。采用聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)方法检测CHD患者及90名健康对照者的ACE基因多态性插入/缺失及AT1R基因多态性(核苷酸位置1166处A→C转换)。结果显示,CHD患者中ACE的DD基因型频率高于对照组(38.5%对14.4%,P<0.001)。患者与对照组之间AT1R A/C基因型频率无差异(10%对13.1%,P>0.05)。AT1R-AC基因型增加了与ACE-DD相关的相对风险。ACE I/D基因型之间的受累冠状动脉血管数量及冠状动脉评分均无差异(P>0.05)。但AT1R-AC基因型患者的受累冠状动脉血管数量及冠状动脉评分显著高于AA基因型患者(P<0.05)。总之,DD基因型可能是中国人CHD和心肌梗死的危险因素,与冠状动脉狭窄的发生无关。AT1R-C等位基因可能增加与ACE-DD基因型相关的相对风险,可能参与冠状动脉狭窄的发生。